Clinical trials
Terminated Cardiomyopathy, Hypertrophic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Celltrion | 1 |
| Duke University | 1 |
| Gilead Sciences | 1 |
| Heart Metabolics Limited | 1 |
| Le Bonheur Children's Hospital | 1 |
| Montefiore Medical Center | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| The Cleveland Clinic | 1 |
| UltraSight | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 13 |
| Cardiomyopathies | 2 |
| Cardiomyopathy, Hypertrophic, Familial | 2 |
| Heart Failure | 2 |
| Angina Pectoris | 1 |
| Aortic Valve Stenosis | 1 |
| Cardiomyopathy, Dilated | 1 |
| Dyspnea | 1 |
| Hypertrophy | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.